Updated on 13 January 2026
Algorithms for colorectal cancer screening programs
Business development manager at Scimia Consulting di Mauro Scimia
Bracciano (RM), Italy
About
We recently developed an algorithm based on a database of 1300 Italian FIT positive patients. In many European countries where the FIT is used as a primary screening test, 75-80% of all positive subjects return a negative colonoscopy. This greatly burdens NHS, mostly where there's a scarce allocation of resources and contributes to make waiting lists for colonoscopies longer. Sometimes in Italy it takes even 18 months to undergo a colonoscopy, greatly endangering patients' health. With our algorithm we can select those patients at greater risk of returning a positive colonoscopy, potentially reducing all procedures by 42%, making life easier for patients, endoscopists and the NHS.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
Carole Conforti
Consultant International project manager at DIGIMEVO
Barcelona, Spain
Project cooperation
Smart Medical Imaging Platform (SDI-to-MIPI, AI‑Ready Endoscopy Video)
Dalım Dündar Yavuz
R&I manager at AORT SAGLIK HIZMETLERI
Istanbul, Türkiye
Project cooperation
Expertise offer: structural mapping of protein-protein interactions in health and disease
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Jordan Chill
Principal investigator - Academia at Bar Ilan University
Ramat Gan, Israel